Project/Area Number |
04670151
|
Research Category |
Grant-in-Aid for General Scientific Research (C)
|
Allocation Type | Single-year Grants |
Research Field |
General medical chemistry
|
Research Institution | Jichi Medical School |
Principal Investigator |
OHTA Shigeo 自治医科大学, 医学部, 助教授 (00125832)
|
Project Period (FY) |
1992 – 1993
|
Project Status |
Completed (Fiscal Year 1993)
|
Budget Amount *help |
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1993: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1992: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
Keywords | Mitochondria / Encepholomyopathy / Mitochondrial DNA / tRNA / Genetic Disease / Protein Synthesis / ミトコンドリアONA / ミトコンドリア / MELAS / 点変異 / 培養細胞 |
Research Abstract |
A new mitochondrial DNA (mtDNA) mutation of tRNA^<Leu(UUR)> at nucleotide position 3271 (MELAS3271) was determined to be involved in the pathogenic process of mitochondrial diseases MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) using intercellular transfer of patient-derived mtDNA to mtDNA-less HeLa cells (p^0 HeLa cells). Cybrid clones containing imported mtDNA exclusively from a MELAS patient with MELAS3271 mtDNA were isolated, and the influence of MELAS3271 mtDNA on mitochondrial translation activity and mitochondrial respiratory complex I enzyme activity were examined. Accumulation of more than 87% MELAS3271 mutant mtDNA in the cybrid clones induced both low complex I activity and abnormal mtDNA-encoded polypeptide synthesis including at least complex I subunit ND6, suggesting involvement of the new MELAS-associated mutation in the pathogenesis.
|